Sana prices at near record IPO, leading pack of Nasdaq newcomers
In a week where 10 biotechs are expected to price their IPOs, three companies kicked things off with a bang.
Sana Biotechnology priced late Wednesday night at $25 per share, announcing it had raised a whopping $587.5 million. Joining Sana on the Nasdaq are Landos Biopharma and Sensei Biotherapeutics, raising $100 million and $133 million each while pricing at $16 and $19, respectively.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 105,400+ biopharma pros reading Endpoints daily — and it's free.